Nevada is currently home to 570 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Las Vegas, Henderson, Reno and Pahrump. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab
NCT05388474
Recruiting
The virological efficacy of ibalizumab has been clearly demonstrated in multiple clinical trials. This study will expand ibalizumab's clinical data set and allow a better understanding of the virologic response durability on ARV regimens with or without ibalizumab in a heterogeneous real-world patient population. Additional data on the efficacy and safety of ibalizumab and its impact on patient reported outcomes will be captured until study end. Primary Objective: To evaluate the long-term eff... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/20/2023
Locations: Las Vegas Research Center, Las Vegas, Nevada
Conditions: HIV Infections, Multi-Antiviral Resistance
Register for Updates
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
NCT02201992
Recruiting
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-sma... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/20/2023
Locations: Carson Tahoe Regional Medical Center, Carson City, Nevada
Conditions: ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II Non-Small Cell Lung Cancer AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7, Stage IIIA Non-Small Cell Lung Cancer AJCC v7
Register for Updates
Overcoming Barriers to Performing CPR Using a Novel, Interactive CPR Game System
NCT05908500
Recruiting
The goal of this prospective trial is to compare CPR skill and attitudes in adolescent students. The main question[s] it aims to answer are: Does a gamified CPR experience improve CPR skill retention compared to standard classroom CPR training? Does a gamified CPR experience improve attitudes/knowledge relating to barriers for women and minorities receiving CPR? Participants will Answer pre-training questionnaires Participate in CPR training Participate in CPR skills testing on the day of tra... Read More
Gender:
All
Ages:
All
Trial Updated:
06/09/2023
Locations: University of Nevada Reno, Reno, Nevada
Conditions: Cardiac Arrest, Out-Of-Hospital
Register for Updates
The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)
NCT04091984
Recruiting
The ProActive registry is a longitudinal, multi-center study with a prospective arm observing clinical care for patients receiving physician ordered Prospera, an allograft rejection test, and a historical control arm collecting data on cases at the same sites whose kidney allograft rejection status was managed with Serum Creatinine SCr/estimated Glomerular Filtration Rate eGFR. This registry will compare patient management and outcomes in patients who receive Prospera (Prospera arm) to the outco... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/08/2023
Locations: University Medical Center of Southern Nevada, Las Vegas, Nevada
Conditions: Kidney Transplant Rejection
Register for Updates
Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia
NCT04447989
Recruiting
This is a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety study of sildenafil in premature infants (inpatient in Neonatal Intensive Care Units (NICUs)) with severe bronchopulmonary dysplasia (BPD).
Gender:
All
Ages:
29 weeks and below
Trial Updated:
06/02/2023
Locations: Children's Hospital of Nevada at University Medical Center, Las Vegas, Nevada
Conditions: Bronchopulmonary Dysplasia of Newborn
Register for Updates
Blood Flow Regulation in Individuals With Down Syndrome - Training Study
NCT04854122
Recruiting
Work capacity is an important predictor of declining health or physical function, and of mortality, and is commonly measured as peak oxygen consumption. Peak oxygen consumption is very low in individuals with Down syndrome, the most prevalent genetic cause of intellectual disability. Previous research suggests individuals with Down syndrome may experience a double disadvantage when they are exercising: they may not be able to increase cardiac output sufficiently and they may not be able to alloc... Read More
Gender:
All
Ages:
Between 18 years and 35 years
Trial Updated:
05/24/2023
Locations: University of Nevada, Las Vegas, Las Vegas, Nevada
Conditions: Down Syndrome
Register for Updates
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) Without Center Involved-Diabetic Macular Edema (CI-DME)
NCT04567550
Recruiting
RGX-314 is being developed as a novel, potential one-time gene therapy treatment for the treatment of diabetic retinopathy, a chronic and progressive complication of diabetes mellitus. Diabetic retinopathy (DR) is a sight-threatening disease characterized in the early stages by neuronal and vascular dysfunction in the retina, and later by neovascularization that leads to further deterioration of functional vision. Despite the availability of current treatments, diabetic retinopathy remains the l... Read More
Gender:
All
Ages:
Between 25 years and 89 years
Trial Updated:
05/18/2023
Locations: Sierra Eye Associates, Reno, Nevada
Conditions: Diabetic Retinopathy (DR)
Register for Updates
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD)
NCT04514653
Recruiting
RGX-314 is being developed as a potential novel one-time gene therapy treatment for the treatment of neovascular (wet) age related macular degeneration (wet AMD). Wet AMD is characterized by loss of vision due to new, leaky blood vessel formation in the retina. Wet AMD is a significant cause of vision loss in the United States, Europe and Japan, with up to 2 million people living with wet AMD in these geographies alone. Current anti-VEGF therapies have significantly changed the landscape for tre... Read More
Gender:
All
Ages:
Between 50 years and 89 years
Trial Updated:
05/18/2023
Locations: Reno Location, Reno, Nevada
Conditions: Neovascular Age-Related Macular Degeneration (nAMD)
Register for Updates
Engage for Late-Life Depression and Comorbid Executive Dysfunction
NCT05356611
Recruiting
Although there are an increasing number of mental health treatment adaptations for older adults, there are still a number of factors to consider when making these adaptations. Cognitive decline is one such factor that places significant burden on older adults and can interfere with traditional mental health therapies. Engage is a behavioral treatment approach that has shown to be effective in treating late life depression. The investigators are testing the feasibility of Engage as a treatment me... Read More
Gender:
All
Ages:
60 years and above
Trial Updated:
05/08/2023
Locations: University of Nevada, Las Vegas, Nevada
Conditions: Depression in Old Age, Psychotherapy, Mild Cognitive Impairment, Executive Dysfunction
Register for Updates
Optetrak Knee System Post Market Clinical Follow-Up
NCT05788757
Recruiting
A Post-Market Domestic (US) and International Data Collection to Assess the Optetrak Knee System
Gender:
All
Ages:
18 years and above
Trial Updated:
04/21/2023
Locations: Nevada Orthopaedic and Spine Center, Las Vegas, Nevada
Conditions: Knee Arthroplasty, Total
Register for Updates
A Post-Market Domestic (US) and International Data Collection to Assess the Truliant Knee System
NCT05653102
Recruiting
A Post-Market Domestic (US) and International Data Collection to Assess the Truliant® Knee System
Gender:
All
Ages:
18 years and above
Trial Updated:
04/21/2023
Locations: Nevada Orthopaedic and Spine Center, Las Vegas, Nevada
Conditions: Knee Arthroplasty, Total
Register for Updates
An Immersion Intervention for Symptoms of PTSD in Student Veterans
NCT05309031
Recruiting
This study will explore the physical and psychological effects of warm water immersion to the chest on student Veterans who experience symptoms of Post-Traumatic Stress Disorder (PTSD) and may also have depression, anxiety and pain.
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
04/14/2023
Locations: UNLV, Las Vegas, Nevada
Conditions: Stress Disorders, Post-Traumatic
Register for Updates